Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 274-499-0 | CAS number: 70247-70-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2015
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 015
- Report date:
- 2015
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- mammalian cell gene mutation assay
Test material
- Reference substance name:
- Disodium 4-[4-[[5-[(2-bromo-1-oxoallyl)amino]-2-sulphonatophenyl]azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]-2,5-dichlorobenzenesulphonate
- EC Number:
- 274-499-0
- EC Name:
- Disodium 4-[4-[[5-[(2-bromo-1-oxoallyl)amino]-2-sulphonatophenyl]azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]-2,5-dichlorobenzenesulphonate
- Cas Number:
- 70247-70-0
- Molecular formula:
- C19H14BrCl2N5O8S2.2Na
- IUPAC Name:
- disodium 4-[4-({5-[(2-bromoacryloyl)amino]-2-sulfonatophenyl}diazenyl)-3-methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl]-2,5-dichlorobenzenesulfonate
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: MC-20/2014
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: Room temperature, protected from light
Method
- Target gene:
- The test substance, FAT 40061/F, was evaluated for its ability to induce forward mutations at the hypoxanthine-guanine phosphoribosyl transferase (HPRT) locus (hprt) of Chinese hamster ovary (CHO) cells, in the presence and absence of an exogenous metabolic activation system (S9), as assayed by colony growth in the presence of 6-thioguanine (TG resistance, TGr).
Species / strain
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Details on mammalian cell type (if applicable):
- The CHO-K1-BH4 cell line is a proline auxotroph with a modal chromosome number of 20, a population doubling time of 12-14 hours, and a cloning efficiency generally greater than 80% (Li et al., 1987). The CHO-K1-BH4 cells used in this study were obtained from A.W. Hsie, Oak Ridge National Laboratories (Oak Ridge, TN).
Frozen stock cultures were tested to confirm the absence of mycoplasma contamination and for karyotpye stability. - Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254-induced rat liver S9 was used as the metabolic activation system.
- Test concentrations with justification for top dose:
- - Preliminary toxicity assay: 9.77, 19.5, 39.1, 78.1, 156, 313, 625, 1250, 2500 and 5000 μg/mL with and without S9.
- Definitive mutagenicity: 17.8, 35.6, 71.2, 142, 190, 253, 338 and 450 μg/mL with S9 and 235.6, 71.2, 142, 190, 253, 338, 450 and 600 μg/mL without S9.
Test substance dilutions were prepared immediately before use and delivered to the test system. - Vehicle / solvent:
- SOLUBILITY TEST:
Water was selected as the solvent of choice based on the solubility of the test substance and compatibility with the target cells. The test substance formed a clear solution in sterile water at a concentration of ~50 mg/mL, the maximum tested.
The vehicle used to prepare the test substance dose formulations, and also used as the vehicle control was distilled water, as indicated below:
- Vehicle: distilled water
- CAS number: 7732-18-5
- Supplier: Gibco
- Lot number: 1662088
- Purity/Grade: Sterile, distilled
- Expiration date: 30 December 2016
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- Water
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- benzo(a)pyrene
- ethylmethanesulphonate
- Remarks:
- EMS is the positive control for the mutagenicity assay without S9. Benzo(a)pyrene is the positive control for themutagenicity assay with S9.
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
Cells were treated for 5 ± 0.5 hours in the presence and absence of S9, by addition of the test and control substance formulations to the treatment medium (with or without S9, as appropriate). This technique has been shown to be an effective method for detecting various chemical mutagens in this test system (Hsie et al., 1981; Li et al., 1987).
Preliminary Toxicity Test for Selection of Dose Levels
Cells were treated with 10 test substance concentrations, as well as the vehicle control, in the presence and absence of S9 using single cultures. The maximum concentration evaluated (5000 μg/mL). Lower concentrations were prepared by 2-fold dilutions. The pH of the cultures was within pH 7 ± 0.5. Therefore, no pH adjustment was necessary to maintain neutral pH in the treatment medium. Osmolality of the vehicle control and the highest concentration also was measured at the beginning of treatment. Concentrations evaluated in the definitive mutation assay were based on adjusted relative survival.
NUMBER OF REPLICATIONS: Duplicate - Evaluation criteria:
- See any other information on materials and methods section
- Statistics:
- See any other information on materials and methods section
Results and discussion
Test resultsopen allclose all
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with
- Genotoxicity:
- ambiguous
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Remarks:
- No visible precipitate was observed at the beginning or end of treatment, and the test substance had no adverse impact on the pH or osmolality of the cultures
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- without
- Genotoxicity:
- positive
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Remarks:
- No visible precipitate was observed at the beginning or end of treatment, and the test substance had no adverse impact on the pH or osmolality of the cultures
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
Any other information on results incl. tables
Results:
Definitive mutagenicity assay:
Based on the results of the preliminary toxicity assay, FAT 40061/F was evaluated in the definitive mutagenicity assay at concentrations of 17.8, 35.6, 71.2, 142, 190, 253, 338 and 450 μg/mL with S9, and 35.6, 71.2, 142, 190, 253, 338, 450 and 600 μg/mL without S9. No visible precipitate was observed at the beginning or end of treatment, and the test substance again had no adverse impact on the pH of the cultures. However, due to unacceptable vehicle cloning efficiency values at the time of selection this trial was not scored for mutagenicity (not shown), and the assay was repeated.
A re-test was conducted under identical conditions. No visible precipitate was observed at the beginning or end of treatment, and the test substance again had no adverse impact on the pH of the cultures. The average adjusted relative survival was 18.11 and 38.84 % at concentrations of 338 μg/mL with S9 and 600 μg/mL without S9, respectively. Cultures treated at concentrations of 71.2, 142, 190, 253 and 338 μg/mL with S9, and 142, 253, 338, 450 and 600 μg/mL without S9, were chosen for mutant selection (cultures treated at concentrations of 17.8 and 35.6 μg/mL with S9 and 35.6, 71.2 and 190 μg/mL without S9 were discarded prior to selection because a sufficient number of other concentrations was available; cultures treated at a concentration of 450 μg/mL with S9 were discarded prior to selection due to excessive cytotoxicity). Statistically significant* increases in mutant frequency were observed with and without S9 (*: p <0.05 and **: p <0.01, respectively). With S9, the increases in mutant frequency observed were 5.30, 7.82*, 5.90, 7.36* and 7.35* at 71.2, 142, 190, 253 and 338 μg/mL concentrations, respectively. Thus, it was evident that the increases observed with S9 were not dose dependent (p >0.05) and were within the historical negative control 95 % confidence limit. In contrast, the increases observed (i.e. 8.96*, 10.33*, 14.89**, 15.44** and 19.80** at the test concentrations of 142, 253, 338, 450 and 600 μg/mL, respectively) without S9 were dose dependent (p <0.01) and exceeded this limit. The positive controls also induced significant increases in mutant frequency (p< 0.01).
All criteria for a valid assay ultimately were met.
CHO/HPRT Assay Historical Control Data (2011 -2013)
Non-activated | S9 -activated | |||
Solvent control | 0.2 microL/mL EMS | Solvent control | 4.0 microL/mL B(a)P | |
Mean MF | 4.2 | 239.2 | 4.4 | 143.1 |
SD | 3.6 | 144 | 3.9 | 76.2 |
Maximum | 15.7 | 764.2 | 16.9 | 314.5 |
Minimum | 0.0 | 12 | 0.0 | 5.8 |
Solvent control (culture medium, distilled water, saline, DMSO, ethanol, acetone or vehicle supplied by Sponsor). It has been demonstrated that all of the above solvents exhibit the same mutant frequency range.
EMS Ethyl methanesulfonate
B(a)P Benzo(a)pyrene MF Mutant frequency per 106 clonable cells
SD Standard deviation
Applicant's summary and conclusion
- Conclusions:
- FAT 40061/F TE was positive in the In Vitro Mammalian Cell Forward Gene Mutation (CHO/HPRT) Assay with Duplicate Cultures in the absence of S9. The results observed in the presence of S9 were considered to be equivocal.
- Executive summary:
The test substance, FAT 40061/F, was evaluated for its ability to induce forward mutations at the hypoxanthine-guanine phosphoribosyl transferase (HPRT) locus (hprt) of Chinese hamster ovary (CHO) cells, in the presence and absence of an exogenous metabolic activation system (S9), as assayed by colony growth in the presence of 6-thioguanine (TG resistance, TGr). FAT 40061/F was prepared in distilled water and evaluated in a preliminary toxicity assay at concentrations of 9.77, 19.5, 39.1, 78.1, 156, 313, 625, 1250, 2500 and 5000 μg/mL with and without S9. No visible precipitate was observed at the beginning or end of treatment, and the test substance had no adverse impact on the pH or osmolality of the cultures. Adjusted relative survival was 8.49 and 25.47 % at a concentration of 313 μg/mL with and without S9, respectively. Adjusted relative survival approximated 0 % at all higher concentrations. Based on these results, FAT 40061/F was evaluated in the definitive mutagenicity assay at concentrations of 17.8, 35.6, 71.2, 142, 190, 253, 338 and 450 μg/mL with S9, and 35.6, 71.2, 142, 190, 253, 338, 450 and 600 μg/mL without S9 (an earlier trial, performed under identical conditions, was not scored for mutagenicity due to unacceptable vehicle cloning efficiency values at the time of selection; not shown). No visible precipitate was observed at the beginning or end of treatment, and the test substance again had no adverse impact on the pH of the cultures. The average adjusted relative survival was 18.11 and 38.84 % at concentrations of 338 μg/mL with S9 and 600 μg/mL without S9, respectively. Cultures treated at concentrations of 71.2, 142, 190, 253 and 338 μg/mL with S9, and 142, 253, 338, 450 and 600 μg/mL without S9, were chosen for mutant selection (cultures treated at concentrations of 17.8 and 35.6 μg/mL with S9, and 35.6, 71.2 and 190 μg/mL without S9, were discarded prior to selection because a sufficient number of other concentrations was available; cultures treated at a concentration of 450 μg/mL with S9 were discarded prior to selection due to excessive cytotoxicity). Statistically significant increases in mutant frequency were observed with and without S9 (*: p <0.05 and **: p <0.01, respectively). With S9, the increases in mutant frequency observed were 5.30, 7.82*, 5.90, 7.36* and 7.35* at 71.2, 142, 190, 253 and 338 μg/mL concentrations, respectively. Thus, it was evident that the increases observed with S9 were not dose dependent (p >0.05) and were within the historical negative control 95 % confidence limit. In contrast, the increases observed (i.e. 8.96*, 10.33*, 14.89**, 15.44** and 19.80** at the test concentrations of 142, 253, 338, 450 and 600 μg/mL, respectively) without S9 were dose dependent (p <0.01) and exceeded this limit. The positive controls also induced significant increases in mutant frequency (p <0.01). Thus, based on the above findings, FAT 40061/F was considered to be positive in the CHO/HPRT Assay with Duplicate Cultures in the absence of S9. The results observed in the presence of S9 were considered to be equivocal.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
